Other Payables (Narrative) (Details) - USD ($)	9 Months Ended		12 Months Ended
Other Payables (Narrative) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2015
Short-term Debt [Line Items]
Proceed to fund working capital expenses	$ 10,000
Other Payables [Member]
Short-term Debt [Line Items]
Debt instrument outstanding	75,826			$ 65,826
Other Payables [Member] \| Two Non-Related Parties [Member]
Short-term Debt [Line Items]
Proceed to fund working capital expenses			$ 65,826
Debt instrument description			The amounts are unsecured and carry no interest rate or repayment terms.
Other Payables [Member] \| Non-Related Party [Member]
Short-term Debt [Line Items]
Proceed to fund working capital expenses	$ 10,000
Debt instrument description	The amounts are unsecured and carry no interest rate or repayment terms.

Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.

PROTO SCRIPT PHARMACEUTICAL CORP 10-Q